Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

Videos

Videos
Changes to Autism Spectrum Disorder in DSM-5
04/02/2014
Darrel A. Regier, MD, MPH, American Psychiatric Association, DSM-5 Task Force Vice Chair, explains changes to autism spectrum disorder in DSM-5.
Darrel A. Regier, MD, MPH, American Psychiatric Association, DSM-5 Task Force Vice Chair, explains changes to autism spectrum disorder in DSM-5.
Darrel A. Regier, MD, MPH,...
04/02/2014
Psych Congress Network
Videos
Video: ONC’s Scott Weinstein outlines the Data Segmentation for Privacy (DS4P) initiative
03/14/2014
After meeting with addiction treatment professionals at last year's NCAD meeting NCAD 2013, a fellow in the Office of the Chief Privacy Officer (part of the Office of the National Coordinator for Health IT), offered a series of comments...
After meeting with addiction treatment professionals at last year's NCAD meeting NCAD 2013, a fellow in the Office of the Chief Privacy Officer (part of the Office of the National Coordinator for Health IT), offered a series of comments...
After meeting with addiction...
03/14/2014
Psych Congress Network
Videos
Are ADHD Medications Neurotoxic or Neuroprotective?
03/07/2014
Timothy Wilens, MD, discusses new research that clarifies whether ADHD medications have neurotoxic, neuroprotective, or neutral effects on the developing brain.
Timothy Wilens, MD, discusses new research that clarifies whether ADHD medications have neurotoxic, neuroprotective, or neutral effects on the developing brain.
Timothy Wilens, MD, discusses...
03/07/2014
Psych Congress Network

Advertisement

Videos
Key Questions for Diagnosing OCD
02/20/2014
Stephen Sobel, MD, and Charles Raison, MD, talk about the important questions clinicians should ask patients to determine whether they have OCD, and how those questions set patients up for success in treatment.
Stephen Sobel, MD, and Charles Raison, MD, talk about the important questions clinicians should ask patients to determine whether they have OCD, and how those questions set patients up for success in treatment.
Stephen Sobel, MD, and Charles...
02/20/2014
Psych Congress Network
Videos
Treatments on the Horizon for Schizophrenia
02/06/2014
Leslie Citrome, MD, MPH, and Charles Raison, MD, discuss the need for more choices in available antipsychotics and the potential for a new generation of antipsychotics with a more favorable metabolic profile.
Leslie Citrome, MD, MPH, and Charles Raison, MD, discuss the need for more choices in available antipsychotics and the potential for a new generation of antipsychotics with a more favorable metabolic profile.
Leslie Citrome, MD, MPH, and...
02/06/2014
Psych Congress Network
Videos
Understanding DSM-5 Diagnostic Criteria for ADHD
01/24/2014
Tim Wilens, MD, talks with Charles Raison, MD, about changes in ADHD diagnostic criteria in DSM-5, including the number of symptoms needed and what relative impairment means when assessing adult ADHD.
Tim Wilens, MD, talks with Charles Raison, MD, about changes in ADHD diagnostic criteria in DSM-5, including the number of symptoms needed and what relative impairment means when assessing adult ADHD.
Tim Wilens, MD, talks with...
01/24/2014
Psych Congress Network

Advertisement

Videos
How Effective is Transcranial Magnetic Stimulation?
01/16/2014
Scott T. Aaronson, MD, and Charles Raison, MD, discuss response rates to transcranial magnetic stimulation (TMS).
Scott T. Aaronson, MD, and Charles Raison, MD, discuss response rates to transcranial magnetic stimulation (TMS).
Scott T. Aaronson, MD, and...
01/16/2014
Psych Congress Network
Videos
Which Patients Are Most At Risk From Cannabis Use?
01/07/2014
Andrew Penn, RN, MS, NP, CNS, APRN-BC: I'm very wary of certain groups of patients using cannabis. It's important for clinicians to identify these patients and help them find alternatives to cannabis use.
Andrew Penn, RN, MS, NP, CNS, APRN-BC: I'm very wary of certain groups of patients using cannabis. It's important for clinicians to identify these patients and help them find alternatives to cannabis use.
Andrew Penn, RN, MS, NP, CNS,...
01/07/2014
Psych Congress Network
Videos
Darrel A. Regier, MD, MPH, Reviews Changes in DSM-5
12/13/2013
Darrel A. Regier, MD, MPH, DSM-5 Task Force Vice Chair, talks with Jon Draud, MS, MD, about changes in DSM-5. He discusses why disorders are not rigidly separated and how DSM-5 reflects those porous boundaries.
Darrel A. Regier, MD, MPH, DSM-5 Task Force Vice Chair, talks with Jon Draud, MS, MD, about changes in DSM-5. He discusses why disorders are not rigidly separated and how DSM-5 reflects those porous boundaries.
Darrel A. Regier, MD, MPH, DSM-5...
12/13/2013
Psych Congress Network

Advertisement

Videos
Identifying Children at Risk for Problems After Parents Deploy
12/06/2013
Doris Greenberg, MD, and Charles Raison, MD, talk about how risk factors for children of deployed parents fit into the larger pattern of people who struggle when faced with stressors. Clinicians can help these patients by doing one important...
Doris Greenberg, MD, and Charles Raison, MD, talk about how risk factors for children of deployed parents fit into the larger pattern of people who struggle when faced with stressors. Clinicians can help these patients by doing one important...
Doris Greenberg, MD, and Charles...
12/06/2013
Psych Congress Network

Advertisement

Advertisement

Advertisement

Advertisement

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Advertisement

Advertisement

Sign Up

Psych Congress Network Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use